Home  |  About us  |  Editorial board  |  Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 1111Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others

ORIGINAL ARTICLE

Cost-effectiveness analysis of three different combinations of inhalers for severe and very severe chronic obstructive pulmonary disease patients at a tertiary care teaching hospital of South India

Altaf Mohammed, Zubedi Ayesha Mubeen, Nazneen Fareesa, Kareemulla Shaik, Ali Syed Amir, Aleemuddin N M, Hannan Hazari Md. Abdul

Year : 2015| Volume: 6| Issue : 3 | Page no: 150-158

   This article has been cited by
 
1 Readmission Risk in Chronic Obstructive Pulmonary Disease Patients: Comparative Study of Nebulized ß2-Agonists
Vamsi Bollu,Annie Guérin,Geneviève Gauthier,Robert Hiscock,Eric Q. Wu
Drugs - Real World Outcomes. 2016;
[Pubmed]  [Google Scholar] [DOI]
2 Economic evaluations of fluticasone-propionate/salmeterol combination therapy for chronic obstructive pulmonary disease: a review of published studies
M. H. Roberts,M. E. Borrego,A. A. Kharat,P. L. Marshik,D. W. Mapel
Expert Review of Pharmacoeconomics & Outcomes Research. 2016; : 1
[Pubmed]  [Google Scholar] [DOI]
3 Importance of Economic Evaluation in Health Care: An Indian Perspective
Amit Dang,Nishkarsh Likhar,Utkarsh Alok
Value in Health Regional Issues. 2016; 9: 78
[Pubmed]  [Google Scholar] [DOI]

 

Read this article